Your institution may have access to this item. Find your institution then sign in to continue.
Title
Myriad settles BRCA disputes and moves on.
Abstract
The article reports on the settlement of patent dispute of GeneDx of Gaithersburg, Maryland with Myriad Genetics Inc. of Salt Lake City, Utah over BRCA testing, the final chapter of Myriad's losing battle to retain its dominance in breast cancer diagnosis in February 2015.